Regeneron Pharmaceuticals (REGN) Posts Q4 Loss of 37c/Share
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $803.90 +0.72%
Revenue Growth %: +21.1%
Financial Fact:
Other collaboration revenue: 191.3M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +21.1%
Financial Fact:
Other collaboration revenue: 191.3M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported Q4 EPS of ($0.37), $0.23 better than the analyst estimate of ($0.60). Revenue for the quarter came in at $123 million versus the consensus estimate of $131.04 million.
For earnings history and earnings-related data on Regeneron Pharmaceuticals, Inc. (REGN) click here.
For earnings history and earnings-related data on Regeneron Pharmaceuticals, Inc. (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Sun Communities completes $1.03B sale of Park Holidays to Aermont
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
